We’ve noticed that you’re using an unsupported browser,
which may result in pages displaying incorrectly.

For a better viewing experience, we recommend upgrading to the latest browser version of:

Skip to main content
You're viewing content for QLD. Change QLD
Call No Win. No Fee.* Call 1800 555 777
1800 555 777
You're viewing content for QLD. Change QLD

Let Us Call You


$30,000 Slater & Gordon Mesothelioma Fellowship Announced

Contact us
Published on

Slater and Gordon has announced the creation of a Fellowship aimed at promoting and supporting scientific research into the devastating asbestos-related condition mesothelioma.

The Slater and Gordon Mesothelioma Fellowship is worth $30,000 over two-years and will be provided to The Baird Institute, based in Newtown. 

The Institute is the only dedicated cardiothoracic surgical training and research institute in Australia. The Fellowship will support the work of their Cancer/Mesothelioma Research Group.

Senior asbestos lawyer Joanne Wade said the Institute was at the cutting edge of mesothelioma research and had an international reputation for excellence.

“Many of our clients live with the devastating effects of mesothelioma everyday because of their exposure to asbestos,” Ms Wade.

“It is a debilitating and painful condition, and sadly the numbers of people expected to develop it have not yet peaked.

“This means that over the coming years more people will get sick, and we must redouble our efforts to raise awareness about the dangers of asbestos and to invest in research into how to manage, and hopefully one day, cure mesothelioma.

“This Fellowship will provide much needed support for the many world class researchers at The Baird Institute who are working to try and find a cure for this most dreadful disease.”

Professor Paul Bannon, Chairman of The Baird Institute said the creation of the Slater and Gordon Mesothelioma Fellowship was an important event for the Institute.

“Mesothelioma remains a devastating condition, but through our research into early detection and surgical management inroads are being made to improve patient care.

“Collaboration and an ‘all hands on deck’ approach are key to further advancement in the management if this condition.”